Category: Translation & Commercialisation

  In order to harness the benefits from medical research it is important to bring all key stakeholders together, including philanthropy, industry, government and academia.  NFMRI’s conference uniquely provides this opportunity, creating an interactive forum to discuss opportunities, issues and ideas. We encourage delegates to submit questions in advance and contribute to the conversation. The […]

VIEW POST

A challenge for funders of research is that it often requires more than research to achieve their ultimate goals. Restricting funding to research is often set out in the terms of; a bequest, a donation, a grant, the constitution and may be a requirement for the funder to maintain charitable status. The outcome funders wish […]

VIEW POST

Author: AusBiotech Innovation in biotechnology is a foundation stone of the future, providing solutions to human and animal disease, climate change, fuel alternatives and food security, as well as improving our quality of life. Australia is a global hub for biotechnology researchers, companies, investors and partners, which is strengthened by innovation-focussed policies and a not-to-be […]

VIEW POST

Written by Dr Geoff Garrett AO FTSE, Chief Scientist of Queensland. SCIENCE VISION Winston Churchill: “The further backward you can look, the further forward you can see”. Steve Jobs: “You can’t connect the dots looking forward; you can only connect them looking backwards”. The Human Genome Project, completed in 2003, took 13 years and cost $2.7 billion. […]

VIEW POST

Could this be a reality?   We all know that not all good ideas gain traction and become reality. This is true for inventors, for business, for things around the home and for medical research. Discoveries and good ideas that are never disclosed and disappear without a trace may later be rediscovered and lead to future […]

VIEW POST

Written by Professor Ian Smith, Monash University Vice-Provost (Research and Research Infrastructure), A number of universities across the globe are recognising the value of Investment in world-class research infrastructure in the form of technology research platforms (TRP’s). These investments are helping to take research and industry collaborations to a new level and also helps create local […]

VIEW POST

Written by Jarred Shein M. H. Carnegie & Co. The Federal Government provides around $2bn a year of cash and/or tax offset incentives to Australian-based companies that are engaged in research and development (R&D) through the R&D tax incentive program. Our belief is that the Government can potentially provide the innovation sector with greater funding, […]

VIEW POST

We have previously written about our excellent academic research capability and that our biotechnology sector is rated 4th in the world. We have also lamented that our ability to connect our early research with impact and commercial opportunities is languishing well behind the OECD and other countries as reported in the Global Innovation Index. In […]

VIEW POST

Professor Peter Rathjen, Vice-Chancellor, The University of Tasmania speaks about “Advancing Australia’s global innovation position”. We would like to thank Professor Rathjen who delivered the keynote address on day 1 of the NFMRI conference “Putting rubber on the road”.    

VIEW POST

Courtesy of Marc Niemes at HealthXN   

VIEW POST

make-a-donation

partner-enquiry

thinking-out-land

Loading

Looking beyond the research and considering translational needs when funding research. How well are your expectations, application and review processes, measures of success and funding strategy aligned with the next steps for translation?

Thank you for voting
You have already voted on this poll!
Please select an option!